R&D The future of drug development: Integrating open source and ... Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start.
Deep Dive The promise and pitfalls of molecular testing in oncology Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.